Cargando…

Treatment and Outcome of Epileptogenic Temporal Cavernous Malformations

BACKGROUND: The aim of this study is to explore the treatment and outcome of epileptogenic temporal lobe cavernous malformations (CMs). METHODS: We analyzed retrospectively the profiles of 52 patients diagnosed as temporal lobe CMs associated with epilepsy. Among the 52 cases, 11 underwent a direct...

Descripción completa

Detalles Bibliográficos
Autores principales: Shan, Yong-Zhi, Fan, Xiao-Tong, Meng, Liang, An, Yang, Xu, Jian-Kun, Zhao, Guo-Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834007/
https://www.ncbi.nlm.nih.gov/pubmed/25836611
http://dx.doi.org/10.4103/0366-6999.154289
_version_ 1782427429714788352
author Shan, Yong-Zhi
Fan, Xiao-Tong
Meng, Liang
An, Yang
Xu, Jian-Kun
Zhao, Guo-Guang
author_facet Shan, Yong-Zhi
Fan, Xiao-Tong
Meng, Liang
An, Yang
Xu, Jian-Kun
Zhao, Guo-Guang
author_sort Shan, Yong-Zhi
collection PubMed
description BACKGROUND: The aim of this study is to explore the treatment and outcome of epileptogenic temporal lobe cavernous malformations (CMs). METHODS: We analyzed retrospectively the profiles of 52 patients diagnosed as temporal lobe CMs associated with epilepsy. Among the 52 cases, 11 underwent a direct resection of CM along with the adjacent zone of hemosiderin rim without electrocorticogram (ECoG) monitoring while the other 41 cases had operations under the guidance of ECoG. Forty-six patients were treated by lesionectomy + hemosiderin rim while the other six were treated by lesionectomy + hemosiderin rim along with extended epileptogenic zone resection. The locations of lesions, the duration of illness, the manifestation, the excision ranges and the outcomes of postoperative follow-up were analyzed, respectively. RESULTS: All of the 52 patients were treated by microsurgery. There was no neurological deficit through the long-term follow-up. Outcomes of seizure control are as follows: 42 patients (80.8%) belong to Engel Class I, 5 patients (9.6%) belong to Engel Class II, 3 patients (5.8%) belong to Engel Class III and 2 patients (3.8%) belong to Engel Class IV. CONCLUSION: Patients with epilepsy caused by temporal CMs should be treated as early as possible. Resection of the lesion and the surrounding hemosiderin zone is necessary. Moreover, an extended excision of epileptogenic cortex or cerebral lobes is needed to achieve a better prognosis if the ECoG indicates the existence of an extra epilepsy onset origin outside the lesion itself.
format Online
Article
Text
id pubmed-4834007
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-48340072016-04-29 Treatment and Outcome of Epileptogenic Temporal Cavernous Malformations Shan, Yong-Zhi Fan, Xiao-Tong Meng, Liang An, Yang Xu, Jian-Kun Zhao, Guo-Guang Chin Med J (Engl) Original Article BACKGROUND: The aim of this study is to explore the treatment and outcome of epileptogenic temporal lobe cavernous malformations (CMs). METHODS: We analyzed retrospectively the profiles of 52 patients diagnosed as temporal lobe CMs associated with epilepsy. Among the 52 cases, 11 underwent a direct resection of CM along with the adjacent zone of hemosiderin rim without electrocorticogram (ECoG) monitoring while the other 41 cases had operations under the guidance of ECoG. Forty-six patients were treated by lesionectomy + hemosiderin rim while the other six were treated by lesionectomy + hemosiderin rim along with extended epileptogenic zone resection. The locations of lesions, the duration of illness, the manifestation, the excision ranges and the outcomes of postoperative follow-up were analyzed, respectively. RESULTS: All of the 52 patients were treated by microsurgery. There was no neurological deficit through the long-term follow-up. Outcomes of seizure control are as follows: 42 patients (80.8%) belong to Engel Class I, 5 patients (9.6%) belong to Engel Class II, 3 patients (5.8%) belong to Engel Class III and 2 patients (3.8%) belong to Engel Class IV. CONCLUSION: Patients with epilepsy caused by temporal CMs should be treated as early as possible. Resection of the lesion and the surrounding hemosiderin zone is necessary. Moreover, an extended excision of epileptogenic cortex or cerebral lobes is needed to achieve a better prognosis if the ECoG indicates the existence of an extra epilepsy onset origin outside the lesion itself. Medknow Publications & Media Pvt Ltd 2015-04-05 /pmc/articles/PMC4834007/ /pubmed/25836611 http://dx.doi.org/10.4103/0366-6999.154289 Text en Copyright: © 2015 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Shan, Yong-Zhi
Fan, Xiao-Tong
Meng, Liang
An, Yang
Xu, Jian-Kun
Zhao, Guo-Guang
Treatment and Outcome of Epileptogenic Temporal Cavernous Malformations
title Treatment and Outcome of Epileptogenic Temporal Cavernous Malformations
title_full Treatment and Outcome of Epileptogenic Temporal Cavernous Malformations
title_fullStr Treatment and Outcome of Epileptogenic Temporal Cavernous Malformations
title_full_unstemmed Treatment and Outcome of Epileptogenic Temporal Cavernous Malformations
title_short Treatment and Outcome of Epileptogenic Temporal Cavernous Malformations
title_sort treatment and outcome of epileptogenic temporal cavernous malformations
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834007/
https://www.ncbi.nlm.nih.gov/pubmed/25836611
http://dx.doi.org/10.4103/0366-6999.154289
work_keys_str_mv AT shanyongzhi treatmentandoutcomeofepileptogenictemporalcavernousmalformations
AT fanxiaotong treatmentandoutcomeofepileptogenictemporalcavernousmalformations
AT mengliang treatmentandoutcomeofepileptogenictemporalcavernousmalformations
AT anyang treatmentandoutcomeofepileptogenictemporalcavernousmalformations
AT xujiankun treatmentandoutcomeofepileptogenictemporalcavernousmalformations
AT zhaoguoguang treatmentandoutcomeofepileptogenictemporalcavernousmalformations